Click here to close now.


News Feed Item

New Online Tool Helps Patient Advocates Navigate Medicines Development and Evaluation Process

INDIANAPOLIS, March 24, 2014 /PRNewswire/ --

A new online, interactive training programme designed to help patient advocates better influence decisions related to access to new medicines was launched today in advance of the 6th  Global  Patient  Congress at Ascot, United Kingdom.

Developed by Eli Lilly and Company in collaboration with internationally renowned experts in the fields of patient involvement and health technology assessment (HTA), the eMEET (Medicine Evaluation Educational Training) online resource is a unique tool designed to help patient advocates navigate the complex world of medicines development, evaluation and assessment. eMEET is endorsed by Health Technology Assessment International (HTAi), the global scientific and professional society for those who produce, use, or encounter HTA.[1]

"The growing role of patient engagement in the medicines evaluation process is one of the key drivers to improving access - and patient advocates have much to contribute," commented clinical expert Professor Ken Paterson, Former Chair, Scottish Medicines Consortium. "By helping ensure patients have a voice, it's a win for the healthcare system, a win for the HTA process and most importantly, a win for patients."

Patients have unique knowledge about what it's like to live with an illness, the possible limitations of existing treatments and the potential of new therapies. However, ensuring that patients' experiences are considered can be challenging in an environment where decisions are scientifically based.

"It's absolutely crucial that patient advocates understand the medicine development and HTA processes. Advocates can then make a more robust contribution to the medicines evaluation discussion and be accepted as an equal and knowledgeable stakeholder in healthcare decisions," said Kathy Oliver, Co-director for the International Brain Tumour Alliance (IBTA). "eMEET is a great resource. It's easily accessible online, you can learn at your own pace, and it's an enjoyable and valuable educational tool."

eMEET uses a variety of tools, such as video presentations, animations and exercises to show how patients' experiences can be integrated into these complex processes. The programme helps patient advocates ensure, in the most productive and meaningful way, that their input to the medicines evaluation process successfully highlights patient issues, informs decision-making and aligns with the scientific evidence.

"Evidence from patients can help us understand the challenges associated with current therapies and what they would want from new treatments," said Dr. Karen Facey, HTAi Interest Group for Patient/Citizen involvement in HTA. "This can help us put the scientific evidence into context and understand the true value of a treatment."

The eMEET training programme is presented in modules focused on:

  1. Introduction  and  scene-setting  - the  true  value  of  the  patient  voice
  2. The  journey  of  a  medicine - the  complex  process  of  medicines  discovery,  development  and  evaluation
  3. An  introduction  to  HTA
  4. HTA  in  practice - an  illustration  of  the  complexities  of  health  technology  assessment
  5. Patient  advocacy  group  participation  in  HTA  - how  to  engage  effectively  to  ensure  that  HTA  panels  understand  patients'  needs  and  preferences

eMEET is the online component of the broader MEET programme. Translated into multiple languages, MEET was developed as an interactive one-day training workshop designed to help patient advocacy group leaders understand and engage in the journey of a medicine, including: clinical trials, regulatory evaluation and HTA. eMEET does not focus on any specific disease state. MEET and eMEET are part of the advocacy component of PACE (Patient Access to Cancer care Excellence), a Lilly Oncology initiative. For more information, please visit

To view the multi-media press release, including the MEET video testimonials, eMEET teaser video and eMEET brochure please click the link below.

About  HTA

According to Health Technology Assessment International's "HTAi Patient and Consumer Glossary," health technology assessment is the "systematic evaluation of the clinical effectiveness and/or cost-effectiveness and/or the social and ethical impact of a health technology" (such as a medicine) "on the lives of patients and the healthcare system." Its aim is to educate healthcare policymakers. HTA organisations, such as NICE (National Institute for Health and Care Excellence) in the United Kingdom, recommend whether a specific health technology should be used, and if so, in which setting and for which patients. According to the glossary, "assessments vary, but most look at the health benefits and risks of using the technology. They also look at costs and any wider impacts that the technology might have on a population or on society."[2]

About  PACE 

Created by Lilly Oncology as a global collaboration spanning diverse sectors, PACE (Patient Access to Cancer care Excellence) exists to encourage public policies and healthcare decisions that speed the development of new medicines, assure cancer treatments respond to the needs and qualities of individual patients, and improve patient access to the most effective cancer medicines. PACE is engaging key oncology stakeholders: patients, advocacy, payers, policymakers, providers, the public, researchers and politicians. To learn more about PACE and the PACE  Cancer  Perception  Index, please visit

About  Lilly  Oncology

For more than fifty years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world. To learn more about Lilly's commitment to people with cancer, please visit

About Eli Lilly and Company

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at and


1. Health Technology Assessment International. What is HTAi? Available at Accessed 21 March 2014.

2. Health Technology Assessment International. HTAi Patient and Consumer Glossary: A beginner’s guide to words used in health technology assessment. October 2009. Available at Accessed 21 March 2014.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Catchpoint, a global leader in monitoring, and testing the performance of online applications, has been named "Silver Sponsor" of DevOps Summit New York, which will take place on June 7-9, 2016 at the Javits Center in New York City. Catchpoint radically transforms the way businesses manage, monitor, and test the performance of online applications. Truly understand and improve user experience with clear visibility into complex, distributed online systems.Founde...
Today air travel is a minefield of delays, hassles and customer disappointment. Airlines struggle to revitalize the experience. GE and M2Mi will demonstrate practical examples of how IoT solutions are helping airlines bring back personalization, reduce trip time and improve reliability. In their session at @ThingsExpo, Shyam Varan Nath, Principal Architect with GE, and Dr. Sarah Cooper, M2Mi’s VP Business Development and Engineering, explored the IoT cloud-based platform technologies driving t...
"eFolder does a lot of different things but we protect data and we are focused on protecting data no matter where it resides," explained Carlo Tapia, Product Marketing Manager at eFolder, in this interview at Cloud Expo, held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA.
The Internet of Things (IoT) is growing rapidly by extending current technologies, products and networks. By 2020, Cisco estimates there will be 50 billion connected devices. Gartner has forecast revenues of over $300 billion, just to IoT suppliers. Now is the time to figure out how you’ll make money – not just create innovative products. With hundreds of new products and companies jumping into the IoT fray every month, there’s no shortage of innovation. Despite this, McKinsey/VisionMobile data...
Cloud computing is unquestionably one of the driving forces of DevOps, as the automation of operations transforms enterprise software development. DevOps, however, is more than a technology trend, as it represents a move toward silo-busting, self-organizing horizontal teams that drive business velocity. At the same time, enterprise Digital Transformation represents an upheaval across the enterprise, as customer preferences and behavior drive enterprise technology decisions. This transformation ...
Most of the IoT Gateway scenarios involve collecting data from machines/processing and pushing data upstream to cloud for further analytics. The gateway hardware varies from Raspberry Pi to Industrial PCs. The document states the process of allowing deploying polyglot data pipelining software with the clear notion of supporting immutability. In his session at @ThingsExpo, Shashank Jain, a development architect for SAP Labs, discussed the objective, which is to automate the IoT deployment proces...
Just over a week ago I received a long and loud sustained applause for a presentation I delivered at this year’s Cloud Expo in Santa Clara. I was extremely pleased with the turnout and had some very good conversations with many of the attendees. Over the next few days I had many more meaningful conversations and was not only happy with the results but also learned a few new things. Here is everything I learned in those three days distilled into three short points.
DevOps is about increasing efficiency, but nothing is more inefficient than building the same application twice. However, this is a routine occurrence with enterprise applications that need both a rich desktop web interface and strong mobile support. With recent technological advances from Isomorphic Software and others, rich desktop and tuned mobile experiences can now be created with a single codebase – without compromising functionality, performance or usability. In his session at DevOps Su...
In demand-intensive mobile and web applications, an emerging pattern is to host the Systems of Engagement in the cloud (for maximum responsiveness) but keep the Systems of Record with the other important business systems in the company datacenter, often on a tightly secured mainframe. But what about the space in between? In this IBM Redpaper publication, we show that the IBM Bluemix cloud platform offers technologies that make it easy for cloud-based SoEs to securely connect to on-premises IBM...
As organizations realize the scope of the Internet of Things, gaining key insights from Big Data, through the use of advanced analytics, becomes crucial. However, IoT also creates the need for petabyte scale storage of data from millions of devices. A new type of Storage is required which seamlessly integrates robust data analytics with massive scale. These storage systems will act as “smart systems” provide in-place analytics that speed discovery and enable businesses to quickly derive meaningf...
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
In his General Session at 17th Cloud Expo, Bruce Swann, Senior Product Marketing Manager for Adobe Campaign, explored the key ingredients of cross-channel marketing in a digital world. Learn how the Adobe Marketing Cloud can help marketers embrace opportunities for personalized, relevant and real-time customer engagement across offline (direct mail, point of sale, call center) and digital (email, website, SMS, mobile apps, social networks, connected objects).
OpsHub, Inc. has announced enhanced support for DevOps and Migration for both Team Foundation Server and Visual Studio On-line in a heterogeneous environment. With added support for build and release entities in OpsHub Integration Manager (OIM) Microsoft customers can now leverage Visual Studio build and release services to manage DevOps processes in a heterogeneous environment. With the enhanced support customers can manage the DevOps process in Team Foundation Server while undertaking activit...
The buzz continues for cloud, data analytics and the Internet of Things (IoT) and their collective impact across all industries. But a new conversation is emerging - how do companies use industry disruption and technology enablers to lead in markets undergoing change, uncertainty and ambiguity? Organizations of all sizes need to evolve and transform, often under massive pressure, as industry lines blur and merge and traditional business models are assaulted and turned upside down. In this new da...
With all the incredible momentum behind the Internet of Things (IoT) industry, it is easy to forget that not a single CEO wakes up and wonders if “my IoT is broken.” What they wonder is if they are making the right decisions to do all they can to increase revenue, decrease costs, and improve customer experience – effectively the same challenges they have always had in growing their business. The exciting thing about the IoT industry is now these decisions can be better, faster, and smarter. Now ...